County of Los Angeles

County of Los Angeles was paid $19.75M by Medicaid between Jan 2018 and Dec 2024, across 699 billing codes. Its largest line is 0450, Emergency room services — 20% of everything it billed.

33Billing provider infoCOUNTY OF LOS ANGELES
LOS ANGELES, CA 90033

33aNPI1699986331assigned 05/24/2007

33bProvider typeGeneral Acute Care Hospital

28Total paid$19.75M

24GClaims3,810,974

24DCodes billed699

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#124 of 410

Median peer was paid$6.90M

This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	230,716	$875.72
2019	341,369	$882K
2020	431,331	$2.54M
2021	562,357	$3.26M
2022	656,249	$4.24M
2023	754,121	$5.02M
2024incomplete	834,831	$3.81M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	20%	85,162	73,146	$3.91M
74174		6.4%	18,144	16,695	$1.27M
99205	Prolong outpt/office vis	5.9%	10,957	9,883	$1.17M
70450	Computed tomography, head or brain; without contrast material	3.9%	22,420	20,388	$762K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.7%	81,920	68,740	$530K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.3%	58,174	55,235	$459K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.3%	25,989	23,841	$446K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.2%	33,213	31,874	$426K
0111		2.0%	17,614	4,034	$400K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	1.9%	9,506	8,747	$374K
72125	Computed tomography, cervical spine; without contrast material	1.9%	5,907	5,492	$373K
71260	Computed tomography, thorax, diagnostic; with contrast material	1.8%	6,490	6,146	$352K

687 more codes

G9008	Coordinated care fee, physician coordinated care oversight services	1.8%	16,364	$352K
G0378	Hospital observation service, per hour	1.7%	1,501	$330K
0510		1.6%	21,021	$326K
99199	Unlisted special service, procedure or report	1.6%	6,623	$324K
0200		1.4%	4,823	$276K
80048	Basic metabolic panel (calcium, ionized)	1.2%	57,175	$241K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	80,747	$234K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	9,510	$232K
J9271	Injection, pembrolizumab, 1 mg	1.1%	2,631	$218K
71045	Radiologic examination, chest; single view	1.1%	54,060	$209K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	5,436	$182K
80076		<1%	30,197	$148K
70486		<1%	2,327	$139K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	6,401	$132K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,711	$123K
0760		<1%	6,747	$121K
99285	Emergency room visit (most serious)	<1%	5,341	$118K
G9012	Other specified case management service not elsewhere classified	<1%	535	$114K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	11,483	$114K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	11,868	$114K
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	554	$108K
71046	Radiologic examination, chest; 2 views	<1%	24,260	$107K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	48,737	$105K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	11,133	$102K
93971		<1%	5,369	$101K
83880		<1%	5,924	$100K
83690		<1%	19,761	$88K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,667	$88K
70498		<1%	1,684	$86K
84484		<1%	11,643	$86K
93970		<1%	3,403	$85K
0250		<1%	60,532	$83K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,270	$82K
80053	Comprehensive metabolic panel	<1%	47,118	$80K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	17,856	$71K
J7030	Infusion, normal saline solution , 1000 cc	<1%	36,466	$68K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	1,517	$68K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,275	$65K
83605		<1%	9,004	$65K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	7,018	$63K
73610		<1%	8,113	$63K
73564		<1%	6,398	$62K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	3,773	$60K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	963	$59K
86780		<1%	8,834	$58K
73110		<1%	6,775	$56K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	17,414	$50K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,564	$46K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,699	$45K
87522	Neg quan hep c or qual rna	<1%	6,240	$45K
85610		<1%	31,424	$45K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	22,871	$44K
86703		<1%	9,659	$44K
70496		<1%	603	$44K
73030		<1%	5,636	$43K
73590		<1%	5,485	$42K
99221		<1%	1,156	$40K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	32,927	$40K
73130		<1%	5,313	$40K
73080		<1%	3,845	$40K
J9306	Injection, pertuzumab, 1 mg	<1%	996	$39K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	11,111	$39K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,037	$38K
90715		<1%	4,926	$36K
73090		<1%	4,364	$36K
86141		<1%	8,538	$35K
S5551	Insulin, most rapid onset (lispro or aspart); 5 units	<1%	7,809	$35K
76801		<1%	2,272	$35K
73630		<1%	5,619	$33K
87536		<1%	2,978	$33K
J9145	Injection, daratumumab, 10 mg	<1%	862	$33K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	23,932	$32K
J9041	Injection, bortezomib, 0.1 mg	<1%	1,847	$32K
77066	Tomosynthesis, mammo	<1%	1,547	$31K
99232	Hospital visit by a doctor, follow-up day	<1%	1,028	$31K
90792	Psychiatric diagnostic evaluation with medical services	<1%	6,123	$31K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	15,082	$31K
86850		<1%	9,657	$31K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	543	$30K
0100		<1%	601	$29K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	3,839	$29K
87040		<1%	3,342	$28K
80047		<1%	7,895	$28K
82550		<1%	5,919	$27K
84702		<1%	4,029	$26K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	20,746	$25K
81001		<1%	20,463	$25K
80305		<1%	5,084	$25K
87086	Culture, bacterial; quantitative colony count, urine	<1%	10,012	$25K
73120		<1%	3,290	$23K
85730		<1%	8,786	$23K
70491		<1%	549	$22K
76642		<1%	2,118	$22K
86480		<1%	4,671	$22K
76770		<1%	1,574	$22K
36415	Collection of venous blood by venipuncture	<1%	432,721	$22K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,036	$21K
86901		<1%	10,961	$21K
73620		<1%	3,343	$21K
73562		<1%	2,638	$20K
71250		<1%	700	$20K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	11,200	$20K
73700		<1%	639	$19K
76870		<1%	1,698	$19K
86900		<1%	10,310	$19K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	7,964	$19K
73060		<1%	2,357	$18K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	108,995	$18K
59025	Fetal non-stress test	<1%	8,318	$17K
83036	Hemoglobin; glycosylated (A1C)	<1%	27,591	$17K
19083		<1%	1,614	$17K
80061	Lipid panel	<1%	17,103	$16K
88182		<1%	1,026	$16K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,498	$15K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	405	$15K
76830	Ultrasound, transvaginal	<1%	833	$15K
72100		<1%	2,332	$15K
J2560	Injection, phenobarbital sodium, up to 120 mg	<1%	263	$15K
J2704	Injection, propofol, 10 mg	<1%	7,360	$15K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	2,553	$14K
73552		<1%	1,946	$14K
94760		<1%	10,125	$13K
85027		<1%	16,382	$13K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	268	$13K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	441	$13K
Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	<1%	1,558	$13K
99213	Doctor's office visit, returning patient (routine)	<1%	127,686	$13K
74018		<1%	3,433	$13K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	352	$12K
J1170	Injection, hydromorphone, up to 4 mg	<1%	10,711	$12K
99381		<1%	1,626	$12K
J1630	Injection, haloperidol, up to 5 mg	<1%	7,620	$11K
77065	Tomosynthesis, mammo	<1%	523	$11K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,564	$11K
90677		<1%	3,452	$11K
J0178	Injection, aflibercept, 1 mg	<1%	439	$11K
86360		<1%	1,634	$11K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	149	$11K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,863	$10K
81000		<1%	24,741	$10K
83735		<1%	8,674	$10K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	229	$10K
J9299	Injection, nivolumab, 1 mg	<1%	1,166	$10K
72170		<1%	1,387	$10K
80074		<1%	763	$10K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	782	$9K
97161		<1%	13,162	$9K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	9,165	$9K
88342		<1%	2,696	$9K
86593		<1%	5,362	$9K
J0690	Injection, cefazolin sodium, 500 mg	<1%	6,717	$9K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	252	$9K
87186		<1%	2,685	$9K
92557		<1%	4,018	$8K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	21,392	$8K
0516		<1%	467	$8K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	28,601	$8K
86592		<1%	5,245	$8K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	843	$8K
99222	Initial hospital care, per day, moderate complexity	<1%	132	$8K
73502		<1%	882	$8K
84443	Thyroid stimulating hormone (TSH)	<1%	3,717	$8K
P9011	Blood, split unit	<1%	838	$8K
72141		<1%	82	$8K
90750		<1%	3,430	$8K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	496	$8K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,498	$8K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,856	$7K
87340		<1%	4,000	$7K
93017		<1%	1,735	$7K
J0490	Injection, belimumab, 10 mg	<1%	855	$7K
99238	Hospital discharge day management, 30 minutes or less	<1%	209	$7K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	4,742	$7K
86920		<1%	3,247	$7K
84100		<1%	8,621	$6K
70487		<1%	158	$6K
J1953	Injection, levetiracetam, 10 mg	<1%	2,546	$6K
J7050	Infusion, normal saline solution, 250 cc	<1%	47,456	$6K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	757	$6K
90791	Psychiatric diagnostic evaluation	<1%	1,128	$6K
J1750	Injection, iron dextran, 50 mg	<1%	499	$6K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,239	$6K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	478	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,985	$6K
73501		<1%	560	$6K
85378		<1%	1,558	$6K
84439		<1%	4,610	$6K
73140		<1%	1,777	$6K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	17,439	$6K
96415		<1%	2,257	$5K
J2357	Injection, omalizumab, 5 mg	<1%	1,954	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	36,130	$5K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	1,648	$5K
Q3014	Telehealth originating site facility fee	<1%	1,040	$5K
87088		<1%	4,860	$5K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	12,160	$5K
67028	Intravitreal injection of a pharmacologic agent	<1%	17	$5K
J3262	Injection, tocilizumab, 1 mg	<1%	486	$5K
J2060	Injection, lorazepam, 2 mg	<1%	6,273	$5K
81003		<1%	6,329	$5K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	6,352	$5K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	4,912	$5K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	7,841	$5K
0113		<1%	191	$5K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,013	$5K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	24,622	$5K
82962		<1%	12,956	$5K
99243		<1%	2,510	$5K
J9267	Injection, paclitaxel, 1 mg	<1%	2,755	$5K
J2997	Injection, alteplase recombinant, 1 mg	<1%	98	$5K
81015		<1%	5,731	$5K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	982	$4K
99244	Office or other outpatient consultation, moderate to high complexity	<1%	932	$4K
73503		<1%	347	$4K
85652		<1%	5,483	$4K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,461	$4K
73000		<1%	571	$4K
J1644	Injection, heparin sodium, per 1000 units	<1%	10,465	$4K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	1,911	$4K
80422		<1%	1,020	$4K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,038	$4K
88187		<1%	9,850	$4K
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,541	$4K
90723		<1%	1,109	$4K
74181		<1%	37	$4K
51702		<1%	1,822	$4K
90651		<1%	1,685	$4K
73070		<1%	841	$4K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	393	$4K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,475	$4K
82140		<1%	436	$4K
99442		<1%	61,793	$4K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	7,199	$4K
87210		<1%	3,845	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,591	$3K
83970		<1%	1,173	$3K
J1940	Injection, furosemide, up to 20 mg	<1%	4,286	$3K
82607		<1%	2,177	$3K
73100		<1%	1,218	$3K
82728		<1%	3,271	$3K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,387	$3K
83026		<1%	3,654	$3K
86705		<1%	2,022	$3K
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	1,563	$3K
96375	Therapeutic injection; each additional sequential IV push	<1%	273	$3K
86706		<1%	2,743	$3K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,032	$3K
J2182	Injection, mepolizumab, 1 mg	<1%	81	$3K
92134		<1%	3,853	$3K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	4,905	$3K
88341		<1%	250	$3K
84703		<1%	1,517	$3K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,207	$3K
72040		<1%	727	$3K
J8540	Dexamethasone, oral, 0.25 mg	<1%	12,414	$3K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	9,927	$3K
88304		<1%	2,449	$3K
72158		<1%	38	$3K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	12	$3K
74170		<1%	66	$3K
88142		<1%	8,891	$3K
99203	Doctor's office visit, new patient (routine)	<1%	22,598	$3K
87205		<1%	2,693	$3K
85007		<1%	2,752	$3K
J9171	Injection, docetaxel, 1 mg	<1%	550	$3K
90680		<1%	655	$3K
29075		<1%	1,770	$3K
93880		<1%	406	$3K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	20	$3K
82746		<1%	1,307	$3K
84153		<1%	2,400	$3K
92250		<1%	2,852	$3K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,348	$2K
92235		<1%	2,162	$2K
29705		<1%	2,192	$2K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	17	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,504	$2K
90670		<1%	647	$2K
83550		<1%	3,220	$2K
93922		<1%	697	$2K
81002		<1%	3,648	$2K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	1,259	$2K
96417		<1%	906	$2K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	4,736	$2K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	633	$2K
90686		<1%	7,404	$2K
88309		<1%	50	$2K
78815	Positron emission tomography (PET) for limited area imaging	<1%	13	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	292	$2K
99242		<1%	360	$2K
83540		<1%	3,326	$2K
86762		<1%	528	$2K
0300		<1%	7,887	$2K
87070		<1%	1,779	$2K
73600		<1%	395	$2K
94660		<1%	607	$2K
J9070	Cyclophosphamide, 100 mg	<1%	347	$2K
76536		<1%	228	$2K
95811		<1%	966	$2K
51798		<1%	861	$2K
92550		<1%	1,446	$2K
84403		<1%	676	$2K
83615		<1%	2,271	$2K
86160		<1%	826	$2K
J2315	Injection, naltrexone, depot form, 1 mg	<1%	43	$2K
95909		<1%	1,230	$2K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	3,033	$1K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	500	$1K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	228,745	$1K
82248		<1%	2,132	$1K
99443		<1%	28,224	$1K
92591		<1%	453	$1K
G0390	Trauma response team associated with hospital critical care service	<1%	51	$1K
99254		<1%	31	$1K
81025		<1%	5,257	$1K
J9190	Injection, fluorouracil, 500 mg	<1%	4,611	$1K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,519	$1K
J7642	Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram	<1%	1,432	$1K
97165		<1%	1,428	$1K
80329		<1%	2,187	$1K
82105		<1%	674	$1K
87147		<1%	491	$1K
89050		<1%	908	$1K
99441		<1%	28,742	$1K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,102	$1K
73560		<1%	318	$1K
J3360	Injection, diazepam, up to 5 mg	<1%	793	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	3,278	$1K
90648		<1%	1,539	$1K
82570		<1%	3,657	$1K
82378		<1%	514	$1K
92002		<1%	859	$1K
86039		<1%	532	$997.54
51700		<1%	347	$976.16
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	276	$953.43
85008		<1%	1,926	$952.35
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	220	$943.91
82043		<1%	4,445	$917.57
G9920	Screening performed and negative	<1%	1,749	$910.72
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,076	$882.56
95911		<1%	665	$881.44
J9263	Injection, oxaliplatin, 0.5 mg	<1%	2,718	$873.45
86304		<1%	1,231	$845.12
86708		<1%	502	$844.08
72131		<1%	15	$835.36
88173		<1%	923	$816.58
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	23,724	$810.81
92133		<1%	1,120	$809.74
82010		<1%	163	$800.79
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	422	$790.24
84146		<1%	299	$777.69
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	1,328	$765.87
94726		<1%	410	$738.93
92567		<1%	2,509	$727.97
82565		<1%	4,875	$718.57
95910		<1%	87	$717.73
90739		<1%	1,497	$716.73
93926		<1%	139	$707.80
S5550	Insulin, rapid onset, 5 units	<1%	2,002	$702.28
31720		<1%	584	$696.57
74183		<1%	12	$694.04
82540		<1%	4,535	$685.59
87081		<1%	2,099	$673.73
99201		<1%	3,407	$656.48
94010		<1%	3,770	$652.48
82784		<1%	540	$646.39
78816		<1%	13	$637.94
97803		<1%	189	$633.60
94729		<1%	695	$626.20
90710		<1%	463	$607.05
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	5,709	$599.76
88307		<1%	687	$590.93
84145		<1%	194	$587.87
93247		<1%	844	$587.64
97802		<1%	130	$581.27
J3489	Injection, zoledronic acid, 1 mg	<1%	2,746	$580.56
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	14	$576.17
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	9,314	$563.67
90716		<1%	513	$563.03
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,714	$561.55
88112		<1%	521	$555.63
92227		<1%	3,559	$544.85
97162		<1%	1,359	$543.28
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	639	$518.74
97760		<1%	1,297	$511.81
87581		<1%	26	$511.18
92083		<1%	943	$508.21
92228		<1%	294	$507.34
87116		<1%	1,067	$486.16
J9035	Injection, bevacizumab, 10 mg	<1%	1,276	$483.05
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	4,659	$473.10
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	885	$470.05
80320		<1%	3,064	$437.31
95886		<1%	28	$425.80
86225		<1%	489	$403.17
87535		<1%	220	$393.40
87338		<1%	2,048	$392.00
99204	Doctor's office visit, new patient (more involved)	<1%	11,498	$390.41
97116		<1%	402	$386.86
72190		<1%	51	$385.20
92015	Determination of refractive state	<1%	4,657	$384.71
80164		<1%	72	$379.14
S5553	Insulin, long acting; 5 units	<1%	1,003	$373.34
90633		<1%	1,031	$369.29
92551		<1%	2,560	$368.24
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	458	$365.68
99214	Doctor's office visit, returning patient (more involved)	<1%	55,220	$362.17
83001		<1%	190	$361.57
90734		<1%	948	$356.83
84550		<1%	761	$356.43
99091		<1%	2,782	$350.10
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	616	$342.83
99382		<1%	727	$335.96
97164		<1%	182	$335.41
70480		<1%	13	$330.04
85384		<1%	148	$329.98
J0640	Injection, leucovorin calcium, per 50 mg	<1%	4,576	$329.40
92504		<1%	1,169	$328.49
88312		<1%	28	$326.77
97166		<1%	649	$322.26
97010		<1%	2,301	$321.30
99385		<1%	477	$319.48
90707		<1%	567	$316.47
99383		<1%	518	$313.81
86800		<1%	178	$312.57
94060		<1%	146	$308.05
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	997	$305.63
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	630	$303.25
87900		<1%	26	$301.24
85044		<1%	598	$296.60
J1815	Injection, insulin, per 5 units	<1%	825	$289.58
A7030	Full face mask used with positive airway pressure device, each	<1%	405	$287.86
95806		<1%	1,673	$282.86
0124A		<1%	334	$279.20
92579		<1%	1,182	$272.53
88141		<1%	1,084	$267.21
87517		<1%	69	$266.69
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	305	$262.85
84165		<1%	297	$261.69
55700		<1%	154	$255.48
J0456	Injection, azithromycin, 500 mg	<1%	429	$254.99
99234		<1%	38	$238.70
90700		<1%	551	$231.15
94618		<1%	1,055	$228.43
90653		<1%	820	$220.91
99024		<1%	3,324	$218.21
87529		<1%	13	$202.44
0002A		<1%	65	$200.00
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	15	$197.29
90746		<1%	163	$196.87
J3490	Unclassified drugs	<1%	1,126	$196.65
93308		<1%	51	$182.82
0001A		<1%	77	$176.94
96900		<1%	385	$173.44
94770		<1%	17	$170.15
85060		<1%	1,174	$164.66
J9206	Injection, irinotecan, 20 mg	<1%	1,470	$164.40
0004A		<1%	15	$160.00
83721		<1%	288	$154.34
86021		<1%	15	$142.92
93990		<1%	115	$140.20
90834	Psychotherapy session, about 45 minutes	<1%	8,765	$134.32
J9045	Injection, carboplatin, 50 mg	<1%	1,559	$132.27
84481		<1%	93	$131.32
86431		<1%	120	$128.59
96367		<1%	31	$123.27
J1956	Injection, levofloxacin, 250 mg	<1%	119	$119.00
0636		<1%	10,963	$116.25
92136		<1%	365	$111.01
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	27	$110.08
90696		<1%	398	$109.59
94002		<1%	235	$109.06
S0028	Injection, famotidine, 20 mg	<1%	630	$104.24
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	126	$101.58
J1453	Injection, fosaprepitant, 1 mg	<1%	1,889	$101.14
73020		<1%	17	$98.86
10021		<1%	118	$96.08
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	824	$95.78
73660		<1%	27	$89.88
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	<1%	205	$88.95
99384		<1%	253	$88.74
92610		<1%	152	$81.09
85014		<1%	106	$76.64
3078F		<1%	43,808	$75.00
87102		<1%	123	$74.78
76098		<1%	351	$73.71
85018		<1%	102	$72.28
73650		<1%	15	$70.92
84166		<1%	56	$66.18
92285		<1%	139	$65.33
93975		<1%	14	$65.08
92025		<1%	194	$64.26
96361	Intravenous infusion, hydration; each additional hour	<1%	102	$63.79
87206		<1%	67	$63.67
83993		<1%	52	$62.54
92582		<1%	683	$60.26
86036		<1%	16	$59.89
76000		<1%	211	$59.75
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	903	$58.25
86376		<1%	32	$57.40
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	258	$56.99
86922		<1%	138	$55.34
J1071	Injection, testosterone cypionate, 1 mg	<1%	1,534	$55.12
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	894	$51.00
J0571	Buprenorphine, oral, 1 mg	<1%	249	$50.40
84540		<1%	396	$49.97
J9370	Vincristine sulfate, 1 mg	<1%	554	$48.74
86301		<1%	45	$48.69
51705		<1%	169	$47.06
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	32	$44.42
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	80	$42.53
94200		<1%	138	$41.91
88300		<1%	229	$40.59
S0030	Injection, metronidazole, 500 mg	<1%	1,308	$39.58
98966		<1%	639	$37.59
J2590	Injection, oxytocin, up to 10 units	<1%	168	$36.08
88313		<1%	57	$34.49
83727		<1%	12	$32.30
89220		<1%	42	$30.78
J2354	Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg	<1%	38	$30.06
3074F		<1%	30,805	$25.00
3077F		<1%	7,132	$25.00
82247		<1%	36	$24.44
86787		<1%	13	$23.91
82274		<1%	7,202	$23.80
96409		<1%	20	$22.45
31575		<1%	428	$22.08
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	326	$20.26
86701		<1%	150	$19.54
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	110	$18.67
84155		<1%	204	$18.63
86300		<1%	107	$18.50
97535	Self-care/home management training, each 15 minutes	<1%	80	$16.35
83516		<1%	13	$14.22
86702		<1%	149	$11.81
82945		<1%	66	$10.52
84300		<1%	53	$9.33
86765		<1%	13	$9.16
88160		<1%	55	$9.08
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	117	$8.69
99173		<1%	510	$8.15
87045		<1%	12	$7.55
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	21	$7.04
98967		<1%	90	$5.99
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	63	$5.63
0401		<1%	15	$4.61
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	192	$2.38
87046		<1%	12	$2.09
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	263	$0.50
91300		<1%	3,395	$0.03
91307		0%	426	$0.00
0110		0%	5,173	$0.00
45380	Colonoscopy, flexible; with biopsy, single or multiple	0%	42	$0.00
99406		0%	232	$0.00
3052F		0%	1,441	$0.00
91305		0%	117	$0.00
59414		0%	234	$0.00
0710		0%	40	$0.00
T1014	Telehealth transmission, per minute, professional services bill separately	0%	3,291	$0.00
99241		0%	52	$0.00
92526		0%	55	$0.00
0771		0%	11,772	$0.00
G8839	Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness	0%	3,566	$0.00
90694		0%	146	$0.00
3079F		0%	7,690	$0.00
0173A		0%	33	$0.00
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	0%	1,668	$0.00
3080F		0%	2,516	$0.00
96161		0%	747	$0.00
99386		0%	29	$0.00
86481		0%	22	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	26	$0.00
90632		0%	33	$0.00
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	0%	134	$0.00
J9250	Methotrexate sodium, 5 mg	0%	18	$0.00
91315		0%	139	$0.00
90732		0%	39	$0.00
3044F		0%	12,398	$0.00
90889		0%	242	$0.00
99465		0%	45	$0.00
0206		0%	398	$0.00
J3357	Ustekinumab, for subcutaneous injection, 1 mg	0%	76	$0.00
96111		0%	103	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	89	$0.00
3075F		0%	7,792	$0.00
52000		0%	16	$0.00
59410		0%	27	$0.00
31231		0%	60	$0.00
J3430	Injection, phytonadione (vitamin k), per 1 mg	0%	29	$0.00
1111F		0%	17,676	$0.00
90620		0%	170	$0.00
93930		0%	38	$0.00
90674		0%	346	$0.00
J9395	Injection, fulvestrant, 25 mg	0%	303	$0.00
99464		0%	75	$0.00
A9152	Single vitamin/mineral/trace element, oral, per dose, not otherwise specified	0%	266	$0.00
95860		0%	105	$0.00
0370		0%	39	$0.00
91317		0%	188	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	61	$0.00
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	0%	116	$0.00
0074A		0%	21	$0.00
82670		0%	26	$0.00
90743		0%	24	$0.00
86704		0%	20	$0.00
H0033	Oral medication administration, direct observation	0%	14	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	33	$0.00
84436		0%	14	$0.00
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	0%	48	$0.00
99606		0%	13	$0.00
86803		0%	20	$0.00
90656		0%	2,894	$0.00
88108		0%	25	$0.00
82985		0%	12	$0.00
0112		0%	52	$0.00
82330		0%	20	$0.00
0761		0%	37	$0.00
51736		0%	16	$0.00
36410		0%	76	$0.00
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	0%	12	$0.00
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	0%	17	$0.00
91303		0%	23	$0.00
74420		0%	14	$0.00
93307		0%	27	$0.00
J0897	Injection, denosumab, 1 mg	0%	304	$0.00
98968		0%	629	$0.00
98960		0%	9,267	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	211	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	45	$0.00
A9901	Dme delivery, set up, and/or dispensing service component of another hcpcs code	0%	352	$0.00
90837	Psychotherapy session, about an hour	0%	1,202	$0.00
H2010	Comprehensive medication services, per 15 minutes	0%	331	$0.00
90611		0%	193	$0.00
H0032	Mental health service plan development by non-physician	0%	68	$0.00
3046F		0%	2,145	$0.00
77062		0%	218	$0.00
90832	Psychotherapy session, about 30 minutes	0%	1,330	$0.00
77080		0%	719	$0.00
90853	Group psychotherapy (other than of a multiple-family group)	0%	982	$0.00
97168		0%	260	$0.00
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	0%	41	$0.00
81479	Unlisted molecular pathology procedure	0%	285	$0.00
92611		0%	134	$0.00
C9257	Injection, bevacizumab, 0.25 mg	0%	693	$0.00
3051F		0%	2,340	$0.00
0120		0%	1,103	$0.00
82947		0%	53	$0.00
90473		0%	499	$0.00
0731		0%	45	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	659	$0.00
93224		0%	41	$0.00
91312		0%	826	$0.00
36600		0%	904	$0.00
H0046	Mental health services, not otherwise specified	0%	675	$0.00
76942		0%	88	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	96	$0.00
93041		0%	596	$0.00
94621		0%	15	$0.00
90658		0%	13	$0.00
43235		0%	42	$0.00
83655		0%	126	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	25	$0.00
77427		0%	307	$0.00
S0197	Prenatal vitamins, 30-day supply	0%	349	$0.00
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	0%	30	$0.00
C1758	Catheter, ureteral	0%	12	$0.00
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	0%	150	$0.00
88302		0%	12	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	103	$0.00
J9303	Injection, panitumumab, 10 mg	0%	60	$0.00
91308		0%	162	$0.00
90460	Immunization administration through 18 years of age via any route, first or only component	0%	20	$0.00
0762		0%	58	$0.00
84156		0%	13	$0.00
80202		0%	31	$0.00
95816		0%	12	$0.00
J3380	Injection, vedolizumab, intravenous, 1 mg	0%	54	$0.00
A4248	Chlorhexidine containing antiseptic, 1 ml	0%	137	$0.00
J1745	Injection, infliximab, excludes biosimilar, 10 mg	0%	15	$0.00
90661		0%	659	$0.00
36555		0%	33	$0.00
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	0%	23	$0.00
90836		0%	24	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	21	$0.00
J9310	Injection, rituximab, 100 mg	0%	15	$0.00
J2185	Injection, meropenem, 100 mg	0%	60	$0.00
J9264	Injection, paclitaxel protein-bound particles, 1 mg	0%	22	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOROZCO, JORGE (CEO)

Same official

Other billing entities under OROZCO, JORGE

Full network →

Provider	Location	Paid
County of Los Angeles	Los Angeles, CA	$216.55M
County of Los Angeles	Los Angeles, CA	$63.83M
County of Los Angeles	Los Angeles, CA	$8.79M
County of Los Angeles	Los Angeles, CA	$1.24M
County of Los Angeles	Los Angeles, CA	$306K
County of Los Angeles	Los Angeles, CA	$26K
County of Los Angeles	Los Angeles, CA	$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.